A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Jha, Mithileshkumar
- Evaluating Minimum Inhibitory Concentration Values of Levofloxacin and Azithromycin on Haemophilus Influenzae
Authors
1 Microbiology, AIIMS, Rishikesh, Uttarakhand, IN
2 Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 10, No 11 (2019), Pagination: 2420-2423Abstract
Background: Community Acquired Pneumonia (CAP) is leading cause of morbidity and mortality in all age groups globally. 4 million cases of Community Acquired Pneumonia occur annually. Haemophilus influenzae is a causative organism of CAP. Empirical treatment with antibiotics like levofloxacin and azithromycin is recommended in these cases.
Objectives: This study was conducted to evaluate the minimum inhibitory concentration of levofloxacin and azithromycin in H. influenzae isolates from respiratory specimens.
Design: Minimum inhibitory concentrations of levofloxacin and azithromycin in 40 clinically significant H.influenzaeisolates were tested using E-test method after the approval of Institutional Ethics committee. The results were analyzed according to 2019 CLSI guidelines.
Result: MIC50 for levofloxacin was 0.008 μg/ml, MIC90 1.5 μg/ml and the 3 resistant isolates had MIC ranging between 8 and 12 μg/ml. Azithromycin MIC50 was 0.047μg/ml, MIC90 6.4 μg/ml and 5 resistant isolates had MIC between 6 and 32μg/ml.
Conclusion: The rising MIC of levofloxacin and azithromycin in H.influenzaeemphasizes the need to monitor the antibiotic susceptibility pattern on a regular basis. It is also advisable to restrain the use of fluoroquinolones to make it available for use in the tuberculosis treatment and also to avoid any adverse effects.